19
Johnson & Johnson Innovative Medicine, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is PALIPERIDONE PALMITATE, with a corresponding application number 207946.
Regulatory Information RX
With a dosage strength 273MG/0.875ML (273MG/0.875ML)
Dosage Form Route SUSPENSION, EXTENDED RELEASE; INTRAMUSCULAR
Reference Listed Drug Yes
Approved since 2015-05-18
18
Johnson & Johnson Innovative Medicine, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is PALIPERIDONE PALMITATE, with a corresponding application number 207946.
Regulatory Information RX
With a dosage strength 1.560GM/5ML (312MG/ML)
Dosage Form Route SUSPENSION, EXTENDED RELEASE; INTRAMUSCULAR
Reference Listed Drug Yes
Approved since 2021-08-30
17
Johnson & Johnson Innovative Medicine, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is PALIPERIDONE PALMITATE, with a corresponding application number 207946.
Regulatory Information RX
With a dosage strength 819MG/2.625ML (312MG/ML)
Dosage Form Route SUSPENSION, EXTENDED RELEASE; INTRAMUSCULAR
Reference Listed Drug Yes
Approved since 2015-05-18
16
Johnson & Johnson Innovative Medicine, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is PALIPERIDONE PALMITATE, with a corresponding application number 207946.
Regulatory Information RX
With a dosage strength 410MG/1.315ML (311.79MG/ML)
Dosage Form Route SUSPENSION, EXTENDED RELEASE; INTRAMUSCULAR
Reference Listed Drug Yes
Approved since 2015-05-18
15
Johnson & Johnson Innovative Medicine, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is PALIPERIDONE PALMITATE, with a corresponding application number 207946.
Regulatory Information RX
With a dosage strength 1.092GM/3.5ML (312MG/ML)
Dosage Form Route SUSPENSION, EXTENDED RELEASE; INTRAMUSCULAR
Reference Listed Drug Yes
Approved since 2021-08-30
14
Johnson & Johnson Innovative Medicine, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is PALIPERIDONE PALMITATE, with a corresponding application number 207946.
Regulatory Information RX
With a dosage strength 546MG/1.75ML (312MG/ML)
Dosage Form Route SUSPENSION, EXTENDED RELEASE; INTRAMUSCULAR
Reference Listed Drug Yes
Approved since 2015-05-18